Trinity Biotech (TRIB) EPS (Basic) (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly EPS (Basic) of -$1.42 for Q4 2024, down 31.35% year-on-year from -$2.06 in Q1 2024, and down 81.88% on a QoQ basis from -$0.78 in Q3 2024.
Trinity Biotech (TRIB) EPS (Basic) (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported EPS (Basic) for 16 consecutive years, with -$1.42 the latest figure, recorded in Q4 2024.
- Quarterly EPS (Basic) fell 31.35% year-over-year to -$1.42 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$1.75 (up 33.96% YoY) and the FY2025 annual result came in at -$3.02, down 13.71% from the prior year.
- EPS (Basic) eased to -$1.42 in Q4 2024 per TRIB's latest filing, from -$0.78 in the prior quarter.
- Over the last five years, EPS (Basic) for TRIB reached as high as $13.14 in Q3 2020 and fell as low as -$22.03 in Q1 2022.
- A 5-year average of -$4.05 and a median of -$1.41 in 2021 frame the typical range for EPS (Basic).
- The largest YoY upside for EPS (Basic) was 29202.1% in 2020 against a maximum downside of 1152183808.05% in 2020.
- Year by year, EPS (Basic) stood at -$17.98 in 2020, then surged by 87.39% to -$2.27 in 2021, then sank by 394.1% to -$11.21 in 2022, then jumped by 90.38% to -$1.08 in 2023, then sank by 31.35% to -$1.42 in 2024.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.42, -$0.78, and -$1.11 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.42 |
| Sep 30, 2024 | -0.78 |
| Jun 30, 2024 | -1.11 |
| Mar 31, 2024 | -0.65 |
| Dec 31, 2023 | -1.08 |
| Sep 30, 2023 | -1.32 |
| Jun 30, 2023 | -1.18 |
| Mar 31, 2023 | -6.46 |
| Dec 31, 2022 | -11.21 |
| Sep 30, 2022 | -11.45 |
| Jun 30, 2022 | -12.43 |
| Mar 31, 2022 | -22.03 |
| Dec 31, 2021 | -2.27 |
| Sep 30, 2021 | 2.37 |
| Jun 30, 2021 | -1.40 |
| Mar 31, 2021 | 2.87 |
| Dec 31, 2020 | -17.98 |
| Sep 30, 2020 | 13.14 |
| Jun 30, 2020 | -2.63 |
| Mar 31, 2020 | -3.99 |